AOD-9604 Research Findings: What the Literature Reports
2026-08-14 · 5 min
This article summarizes how AOD-9604, a peptide fragment derived from human growth hormone, has been studied in the research literature. All findings below come from laboratory and animal models and are not claims about effects in people.
What the research has looked at
- Growth-hormone fragment research. AOD-9604 corresponds to a C-terminal fragment of growth hormone and is studied for the metabolic-related portion of that molecule.
- Fat-metabolism models. Preclinical studies have examined the fragment in animal models of lipid metabolism.
- Mechanistic pharmacology. Research has characterized how the fragment differs from full-length growth hormone in research settings.
What people report anecdotally
Anecdotally, people online often discuss AOD-9604 in the context of fat loss. These are unverified accounts from third parties, not us. They are not effects we have tested or observed, and we cannot promise any of them.
How to read these findings
These observations come from controlled research models. They characterize the compound as a research material and do not establish outcomes in humans. AOD-9604 is supplied as a research compound only, with no human-use framing.
Related reading
See the research catalog for related compounds. Every batch is third-party lab-tested with a COA.
Research use only. This article summarizes laboratory and research-model information only. It is not medical advice and not guidance for human use. Products are not for human or animal consumption.